semaglutide prediabetes weight loss trial progression to diabetes Effect of 2.4 mg once weekly on 10‐year type 2 risk in adults with overweight or obesity - Wilkinson - 2023 - Obesity Semaglutide 2.4 mg clinical outcomes

1 Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea, 2 Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea, 3 Department of BIT Fusion Technology Center, Pusan National University, Busan, Republic of Korea

He added that psychological barriers can often prevent patients from recognizing their addiction and seeking treatment

Mechanisms Underlying Superior Weight and Fat Reduction with Semaglutide As emphasized, in the presented study semaglutide demonstrated superior efficacy in reducing BMI and WCboth key markers of metabolic health and cardiovascular risk

Note the symptom, when it started, its severity, meals or medications taken around that time, hydration, bowel habits, and whether it began after starting treatment or increasing the dose